Use of probiotics in the treatment and/or prevention of psoriasis
US10912802B2 · kind B2 · utility
0Cited by
3References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 21, 2017 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Jul 25, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2035/115
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.